Middle East And Africa Psychedelic Drugs Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 12.14 Million |
 Market Size (Forecast Year) |
USD 27.94 Million |
 CAGR |
% |
| Major Markets Players |
>中东和非洲迷幻药市场，按来源（合成和天然）、类型（致幻剂、解离剂和其他）、药物（γ-羟基丁酸、氯胺酮、裸盖菇素等）、应用（发作性睡病、难治性抑郁症、重度抑郁症、阿片类药物成瘾、创伤后应激障碍等）、给药途径（口服、吸入、注射）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房）划分，行业趋势和预测到 2029 年
中东和非洲迷幻药市场分析与洞察
迷幻药涉及多种化学物质，包括麦角酸二乙酰胺 (LSD) 和从植物中提取的化学物质。这些药物能够改变或增强感官知觉、思维过程、能量水平，据报道还能促进精神体验。
迷幻药可分为共情药和解离药（如苯基环己基哌啶 (PCP)）和血清素药（经典致幻剂），如 LSD。这两种迷幻药都会引起幻觉和感觉，此外，解离药会使人失去对自己身体或环境的控制，使他们感到与世隔绝。根据来源，迷幻药分为天然和合成两种。
这些药物广泛应用于治疗重度抑郁症、创伤后应激障碍、惊恐障碍、难治性抑郁症和阿片类药物成瘾等。迷幻药还有其他几个名字，例如麦角酸衍生物 (LSD) 也被称为吸墨纸、点、糖、酸、旅行和窗格，氯胺酮也被称为维生素 K、肿块、绿色、K/特殊 K、紫色和超酸，PCP 也被称为天使/天使尘、船/爱之船、和平、杀手杂草、超级草和臭氧。
预计中东和非洲市场将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场将以 11.1% 的复合年增长率增长，预计将从 2021 年的 1214 万美元达到 2029 年的 2794 万美元。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020 (可定制至 2019-2014) |
|
定量单位 |
收入（百万美元），定价（美元） |
|
涵盖的领域 |
按来源（合成和天然）、类型（共情剂、解离剂和其他）、药物（γ-羟基丁酸、氯胺酮、裸盖菇素等）、用途（发作性睡病、难治性抑郁症、重度抑郁症、阿片类药物成瘾、创伤后应激障碍等）、给药途径（口服、吸入、注射）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房） |
|
覆盖国家 |
南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区 |
|
涵盖的市场参与者 |
在市场上交易的主要公司包括 Janssen Global Services, LLC（强生服务公司的子公司）、Hikma Pharmaceuticals PLC、辉瑞公司、F. Hoffmann-La Roche Ltd 等 |
市场定义
迷幻药涉及多种化学物质，包括麦角酸二乙酰胺 (LSD) 和从植物中提取的化学物质。这些药物能够改变或增强感官知觉、思维过程、能量水平，据报道还能促进精神体验。
迷幻药可分为共情药和解离药（如苯基环己基哌啶 (PCP)）和血清素药（经典致幻剂），如 LSD。这两种迷幻药都会引起幻觉和感觉，此外，解离药会使人失去对自己身体或环境的控制，使他们感到与世隔绝。根据来源，迷幻药分为天然和合成两种。
这些药物广泛应用于治疗重度抑郁症、创伤后应激障碍、惊恐障碍、难治性抑郁症和阿片类药物成瘾等。迷幻药还有其他几个名字，例如麦角酸衍生物 (LSD)，也称为吸墨纸、点、糖、酸、旅行和窗格，氯胺酮也称为维生素 K、肿块、绿色、K/特殊 K、紫色和超酸，PCP 也称为天使/天使尘、船/爱之船、和平、杀手杂草、超级草和臭氧。
迷幻药市场动态
驱动程序
-
越来越多的人接受迷幻药治疗抑郁症
迷幻药在过去十年中大受欢迎，因为它与人类的精神康复和治疗实践密切相关，具有治愈心灵的力量。越来越多的研究人员和科学家正在探索迷幻药的治疗价值和化合物，这些化合物可能成为抑郁症患者的新治疗选择。迷幻药的持续研究和开发提高了迷幻药的接受度。迷幻药的良好效果增加了南非和其他地区的迷幻药使用量，从而导致对迷幻药的需求增加，因此这些因素有望成为市场增长的驱动力。
-
抑郁症和精神障碍患病率不断上升
精神障碍（或心理疾病）会影响人们的感觉、情绪、思维和行为，可能是长期的（慢性的）或偶尔的。抑郁症和精神障碍会影响个人执行日常任务的能力。精神障碍有很多不同的类型。由于各种因素，包括家族史和基因、虐待或压力、生物因素、饮酒或消遣性药物的使用等，抑郁症和精神障碍在全球范围内有所增加。
此外，非法物质消费的增加也导致抑郁症和精神障碍的增多。因此，抑郁症和精神障碍的患病率不断上升，增加了对迷幻药的需求，而迷幻药有望成为市场增长的动力。
-
提高心理健康意识
由于精神疾病对人们正常生活的能力产生了不利影响，因此，让人们了解精神疾病的不同病因、导致的疾病以及市场上可用的治疗方案变得非常重要，以便治愈这种毁灭生命的疾病。为了提高人们的认识，一些组织和公司正在发起活动和收养计划。这反过来又允许患者根据疾病原因和报告的症状选择有效的治疗方案。广告、宣传活动和其他活动提高了人们对迷幻药的认识。宣传活动鼓励人们选择适当的精神障碍治疗程序和专业人士，这增加了对迷幻药的需求。因此，对心理健康的认识提高有望成为市场增长的动力。
机会
-
增加迷幻药的研发活动
数千年来，迷幻植物和真菌一直被用于本土医药传统。1938 年，阿尔伯特·霍夫曼发起了新型迷幻药开发研究。他合成了第一种麦角酸二乙酰胺 (LSD-25)，五年后被公认为第一个服用 LSD 的人。霍夫曼当时并不知道该产品的重大影响和作用。在 20 世纪 50 年代和 60 年代文化和科学探索不断增长的时期之后，迷幻药开发研究几乎停滞不前。迷幻药研发支出的增加正在为市场创造新的机会。因此，增加迷幻药研发活动是市场增长的机会。
此外，主要市场参与者采取的战略举措将为 2022-2029 年预测期内的迷幻药市场提供结构完整性和未来机会。
克制/挑战
- 迷幻药价格高昂
然而，迷幻药的高成本将阻碍迷幻药市场的增长率。此外，在上述预测期内，严格的规则和法规将进一步挑战市场。
这份迷幻药市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需获取有关迷幻药市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
新冠肺炎疫情对迷幻药市场的影响
COVID-19 对市场产生了积极影响。疫情期间的封锁和隔离使疾病管理和药物依从性变得复杂。因此，世界人口中各种治疗药物的使用量大幅增加。因此，疫情对这个市场产生了积极影响。
近期发展
- 2020 年 8 月，杨森制药公司获批其 Spravato 鼻喷雾剂用于治疗有自杀倾向的人。由于大约 11% 至 12% 的美国人患有导致他们自杀的重度抑郁症，这项批准为这些患者提供了一种卓越的治疗方法，并为公司创造更多收入铺平了道路。
中东和非洲市场范围
中东和非洲迷幻药市场分为来源、类型、药物、应用、给药途径、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
来源
- 合成的
- 自然的
根据来源，中东和非洲迷幻药市场分为合成迷幻药和天然迷幻药。
类型
- 共情因素
- 解离性药物
- 其他的
根据类型，中东和非洲迷幻药市场分为共情剂、分离剂和其他类。
药物
- γ-羟基丁酸
- 氯胺酮
- 裸盖菇素
- 其他的
根据药物类型，中东和非洲迷幻药市场分为γ-羟基丁酸、氯胺酮、裸盖菇素和其他。
。应用
- 嗜睡症，
- 难治性抑郁症
- 重度抑郁症
- 鸦片成瘾
- 创伤后应激障碍
- 其他的
根据应用，中东和非洲迷幻药市场分为发作性睡病、难治性抑郁症、重度抑郁症、阿片类药物成瘾、创伤后应激障碍等。
给药途径
- 口服
- 吸入
- 注射剂
根据给药途径，中东和非洲迷幻药市场分为口服、吸入和注射。
最终用户
- 医院
- 专科诊所
- 家庭护理
- 其他的
根据最终用户，中东和非洲迷幻药市场分为医院、专科诊所、家庭护理和其他。
分销渠道
- 医院药房
- 零售药店
- 网上药店
根据分销渠道，中东和非洲迷幻药市场分为医院药房、零售药房和网上药房。
迷幻药市场区域分析/见解
对迷幻药市场进行了分析，并按国家、来源、类型、药物、应用、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。
本报告涉及的国家包括南非、沙特阿拉伯、阿联酋、埃及、以色列、中东其他地区和非洲。
中东和非洲的沙特阿拉伯在迷幻药市场中占据主导地位，在市场份额和市场收入方面，沙特阿拉伯将继续在预测期内保持主导地位。这是由于该地区正在进行的临床试验和快速的研究发展正在推动市场的发展。
报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。
竞争格局和迷幻药市场份额分析
迷幻药市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对迷幻药市场的关注有关。
迷幻药市场的一些主要参与者包括杨森全球服务有限公司（强生服务公司旗下的子公司）、Hikma Pharmaceuticals PLC、辉瑞公司、罗氏公司等。
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、中东和非洲与地区和供应商份额分析。如有进一步询问，请要求分析师致电
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家名单）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PIPELINE ANALYSIS
4.2 PESTEL ANALYSIS
4.3 PORTER'S FIVE FORCES MODEL
5 REGULATORY FRAMEWORK: MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET
5.1 REGULATORY SCENARIO IN THE U.S.
5.2 REGULATORY SCENARIO IN THE U.K.
5.3 REGULATORY SCENARIO IN INDIA
5.4 REGULATORY SCENARIO IN UAE
5.5 REGULATORY SCENARIO IN AFRICA
5.6 REGULATORY SCENARIO IN BRAZIL
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS TO TREAT DEPRESSION
6.1.2 INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS
6.1.3 RISING AWARENESS TOWARD MENTAL HEALTH
6.1.4 ONGOING CLINICAL TRIALS
6.1.5 RISE IN PRODUCT APPROVALS
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS
6.2.2 HIGH COST OF PSYCHEDELIC DRUGS
6.2.3 PATENT EXPIRY OF PSYCHEDELIC DRUGS
6.3 OPPORTUNITIES
6.3.1 INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS
6.3.2 BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY
6.3.3 UPCOMING REHABILITATION CENTERS
6.3.4 AVAILABILITY OF CERTIFIED HEALTHCARE PROFESSIONALS
6.4 CHALLENGES
6.4.1 SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS
6.4.2 RISE IN ILLEGAL ALTERNATIVES
6.4.3 AVAILABILITY OF OTHER TREATMENT OPTIONS
7 COVID-19 IMPACT ON THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE
8.1 OVERVIEW
8.2 EMPATHOGENS
8.3 DISSOCIATIVES
8.4 OTHERS
9 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE
9.1 OVERVIEW
9.2 SYNTHETIC
9.3 NATURAL
10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS
10.1 OVERVIEW
10.2 GAMMA-HYDROXYBUTYRIC ACID
10.3 KETAMINE
10.4 PSILOCYBIN
10.5 OTHERS
11 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 NARCOLEPSY
11.3 TREATMENT RESISTANT DEPRESSION
11.4 MAJOR DEPRESSIVE DISORDER
11.5 OPIATE ADDICTION
11.6 POST-TRAUMATIC STRESS DISORDER
11.7 OTHERS
12 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 ORAL
12.3 INHALATION
12.4 INJECTABLE
13 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 SPECIALTY CLINICS
13.4 HOMECARE
13.5 OTHERS
14 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 HOSPITALS PHARMACY
14.3 RETAIL PHARMACY
14.4 ONLINE PHARMACY
15 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY REGION
15.1 MIDDLE EAST & AFRICA
15.1.1 SAUDI ARABIA
15.1.2 ISRAEL
15.1.3 EGYPT
15.1.4 UAE
15.1.5 SOUTH AFRICA
16 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 JAZZ PHARMACEUTICALS, INC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 PFIZER INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 F. HOFFMANN- LA ROCHE LTD
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 JANSSEN MIDDLE EAST & AFRICA SERVICES, LLC (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
18.4.1 COMPANY SNAPSHOT
18.4.2 COMPANY SHARE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENT
18.5 AVADEL
18.5.1 COMPANY SNAPSHOT
18.5.2 PRODUCT PORTFOLIO
18.5.3 RECENT DEVELOPMENT
18.6 CELON PHARMA SA
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 COMPASS
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 CYBIN CORP.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 ENTHEON BIOMEDICAL CORP
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 GH RESEARCH
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 HIKMA PHARMACEUTICALS PLC
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 NRX PHARMACEUTICALS, INC.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 PHARMATHER HOLDINGS LTD.
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 VERRIAN
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 USONAINSTITUTE.ORG
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
TABLE 1 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, PIPELINE ANALYSIS
TABLE 2 PSYCHEDELICS RESEARCH STUDIES, IN EUROPE
TABLE 3 MENTAL ILLNESS IN THE U.S. ADULTS, IN 2020
TABLE 4 MENTAL DISORDERS, IN THE U.S. ADULTS, IN 2020
TABLE 5 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS
TABLE 6 THE 1971 UN CONVENTION ON PSYCHOTROPIC SUBSTANCES
TABLE 7 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.
TABLE 8 COST OF PSYCHEDELIC DRUGS
TABLE 9 PSYCHEDELIC DRUGS R&D ACTIVITIES
TABLE 10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA EMPATHOGENS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA DISSOCIATIVES IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA SYNTHETIC IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA NATURAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA GAMMA-HYDROXYBUTYRIC ACID IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA KETAMINE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA PSILOCYBIN IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA NARCOLEPSY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA TREATMENT RESISTANT DEPRESSION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA MAJOR DEPRESSIVE DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA OPIATE ADDICTION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA POST-TRAUMATIC STRESS DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA ORAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA INHALATION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA INJECTABLE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA HOSPITALS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA HOMECARE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA HOSPITALS PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA RETAIL PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA ONLINE PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 50 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 51 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 52 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 53 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 54 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 55 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 56 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 ISRAEL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 ISRAEL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 59 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 60 ISRAEL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 61 ISRAEL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 62 ISRAEL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 63 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 64 EGYPT PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 65 EGYPT PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 66 EGYPT PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 67 EGYPT PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 68 EGYPT PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 69 EGYPT PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 EGYPT PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 71 UAE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 72 UAE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 73 UAE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 74 UAE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 75 UAE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 76 UAE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 77 UAE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 78 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 79 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 80 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 81 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 82 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 83 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 84 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: END USER COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 RISING AWARENESS TOWARDS MERANTAL HEALTH DRIVING THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 EMPATHOGENS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET IN 2022 & 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET
FIGURE 16 MENTAL ILLNESS AMONG THE U.S. ADULTS, IN 2020, (IN %), BY DEMOGRAPHIC GROUPS
FIGURE 17 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2020, (IN %), BY DEMOGRAPHIC GROUPS
FIGURE 18 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2020, (IN %), BY GENDER
FIGURE 19 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, 2021
FIGURE 20 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 22 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, 2021
FIGURE 24 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, 2022-2029 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, CAGR (2022-2029)
FIGURE 26 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, 2021
FIGURE 28 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, 2022-2029 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, CAGR (2022-2029)
FIGURE 30 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, 2021
FIGURE 32 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 33 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 34 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 35 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, 2021
FIGURE 36 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)
FIGURE 37 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)
FIGURE 38 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 39 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, 2021
FIGURE 40 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 41 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 42 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 43 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 44 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 45 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 46 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 47 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2021)
FIGURE 48 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2021)
FIGURE 49 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 50 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 51 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE (2022-2029)
FIGURE 52 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
